Literature DB >> 20104061

Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests.

David A Loewenstein1, Amarilis Acevedo, Elizabeth Potter, John A Schinka, Ashok Raj, Maria T Greig, Joscelyn Agron, Warren W Barker, Yougui Wu, Brent Small, Elizabeth Schofield, Ranjan Duara.   

Abstract

OBJECTIVE: Medial temporal lobe atrophy (MTA) can be used as a biomarker of pathology that affects mechanisms of episodic memory. The authors compared the strength of this biomarker with performance on four memory measures and examined the influence of demographic factors including age, level of education, and primary language (English or Spanish).
METHODS: The Hopkins Verbal Learning Test-revised, Fuld Object Memory Evaluation (FOME), delayed memory for a story passage, and delayed visual reproduction of the Wechsler Memory Scale-revised tests were administered to 281 subjects who were diagnosed as having no cognitive impairment, mild cognitive impairment (MCI), impaired non-MCI, or dementia. MTA scores were obtained from visual ratings of the hippocampus, entorhinal cortex, and perirhinal cortex on coronal magnetic resonance imaging scans using a magnetization-prepared rapid gradient echo protocol.
RESULTS: Age was associated with scores on all memory measures and MTA. Level of educational attainment had no influence on FOME performance but had greater associations with scores on other memory measures. In regression models, FOME scores had the strongest relationship with MTA scores, accounting for 31% of the explained variability. Among subjects with MCI, an index representing the total number of memory tests that were impaired was also predictive of the severity of MTA scores.
CONCLUSION: Among four common tests of memory, the FOME was highly associated with MTA, and it exhibited minimal influences of education. Impairment on more than one memory test was more predictive of MTA than impairment on a single memory test.

Entities:  

Mesh:

Year:  2009        PMID: 20104061     DOI: 10.1097/JGP.0b013e3181b7ef42

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  15 in total

1.  Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.

Authors:  Kathryn P Riley; Gregory A Jicha; Daron Davis; Erin L Abner; Gregory E Cooper; Nancy Stiles; Charles D Smith; Richard J Kryscio; Peter T Nelson; Linda J Van Eldik; Frederick A Schmitt
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder.

Authors:  Mohammad M Herzallah; Ahmed A Moustafa; Joman Y Natsheh; Omar A Danoun; Jessica R Simon; Yasin I Tayem; Mahmud A Sehwail; Ivona Amleh; Issam Bannoura; Georgios Petrides; Catherine E Myers; Mark A Gluck
Journal:  J Affect Disord       Date:  2013-08-13       Impact factor: 4.839

3.  Verbal serial list learning in mild cognitive impairment: a profile analysis of interference, forgetting, and errors.

Authors:  David J Libon; Mark W Bondi; Catherine C Price; Melissa Lamar; Joel Eppig; Denene M Wambach; Christine Nieves; Lisa Delano-Wood; Tania Giovannetti; Carol Lippa; Anahid Kabasakalian; Stephanie Cosentino; Rod Swenson; Dana L Penney
Journal:  J Int Neuropsychol Soc       Date:  2011-09       Impact factor: 2.892

4.  Model-based assessment and neural correlates of spatial memory deficits in mild cognitive impairment.

Authors:  Alexander S Weigard; K Sathian; Benjamin M Hampstead
Journal:  Neuropsychologia       Date:  2019-11-05       Impact factor: 3.139

5.  Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia.

Authors:  Shanna L Burke; Miriam J Rodriguez; Warren Barker; Maria T Greig-Custo; Monica Rosselli; David A Loewenstein; Ranjan Duara
Journal:  J Int Neuropsychol Soc       Date:  2017-09-18       Impact factor: 2.892

Review 6.  Staging neurodegenerative disorders: structural, regional, biomarker, and functional progressions.

Authors:  Trevor Archer; Richard M Kostrzewa; Richard J Beninger; Tomas Palomo
Journal:  Neurotox Res       Date:  2011-02       Impact factor: 3.911

7.  Where did I put that? Patients with amnestic mild cognitive impairment demonstrate widespread reductions in activity during the encoding of ecologically relevant object-location associations.

Authors:  Benjamin M Hampstead; Anthony Y Stringer; Randall F Stilla; Akshay Amaraneni; K Sathian
Journal:  Neuropsychologia       Date:  2011-04-15       Impact factor: 3.139

8.  Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Qian Shen; David A Loewenstein; Elizabeth Potter; Weizhao Zhao; Jason Appel; Maria T Greig; Ashok Raj; Amarilis Acevedo; Elizabeth Schofield; Warren Barker; Yougui Wu; Huntington Potter; Ranjan Duara
Journal:  Alzheimers Dement       Date:  2011-07       Impact factor: 21.566

9.  Assessment of cognition in early dementia.

Authors:  Nina B Silverberg; Laurie M Ryan; Maria C Carrillo; Reisa Sperling; Ronald C Petersen; Holly B Posner; Peter J Snyder; Robin Hilsabeck; Michela Gallagher; Jacob Raber; Albert Rizzo; Katherine Possin; Jonathan King; Jeffrey Kaye; Brian R Ott; Marilyn S Albert; Molly V Wagster; John A Schinka; C Munro Cullum; Sarah T Farias; David Balota; Stephen Rao; David Loewenstein; Andrew E Budson; Jason Brandt; Jennifer J Manly; Lisa Barnes; Adriana Strutt; Tamar H Gollan; Mary Ganguli; Debra Babcock; Irene Litvan; Joel H Kramer; Tanis J Ferman
Journal:  Alzheimers Dement       Date:  2011-05-01       Impact factor: 21.566

10.  MRI markers for mild cognitive impairment: comparisons between white matter integrity and gray matter volume measurements.

Authors:  Yu Zhang; Norbert Schuff; Monica Camacho; Linda L Chao; Thomas P Fletcher; Kristine Yaffe; Susan C Woolley; Catherine Madison; Howard J Rosen; Bruce L Miller; Michael W Weiner
Journal:  PLoS One       Date:  2013-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.